Current Roles

• Director, Clinical Research Center, Saitama Medical University (2020 – Present)

• Director, Public Relations Office, Saitama Medical University (2022 – 2025)

• Professor and Chairman, Department of Otorhinolaryngology, Saitama Medical University (2016 – Present)

Professional Experience

• Vice President, Saitama Medical University Hospital (2018 – 2022)

• Professor, Department of Otorhinolaryngology, Saitama Medical University, Saitama, Japan (2011 – 2016)

• Associate Professor, Department of Otorhinolaryngology, Nippon Medical School, Tokyo, Japan (2007 – 2011)

• Visiting Fellow, National Institutes of Health (NIH), Bethesda, MD, USA (1992 – 1995)

Leadership

• Board Member, Japanese Society of Otorhinolaryngology (2022 – Present)

• Board Member, Japanese Otological Society (2018 – 2024)

• Board Member, Japanese Society for Equilibrium Research (2014 – 2019, 2021 – 2022, 2025-)

• Criteria head, Barany Society Committee for Establishing Diagnostic Criteria of Perilymphatic Fistula

Benjamin S. Bleier, MD, FACS, is a Professor of Otolaryngology-Head and Neck Surgery at Harvard Medical School and the Claire and John Bertucci Chair at Massachusetts Eye and Ear. Dr. Bleier is the Director of Innovation and Commercialization, Endoscopic Skull Base Surgery, and Co-Director of the Center for Thyroid Eye Disease and Orbital Surgery. Dr. Bleier’s R01 funded research has contributed to over 200 peer-reviewed articles, book chapters, and textbooks, 6000 citations, and 10 patents. He lectures internationally on endoscopic management of orbit and skull base tumors as well as intranasal drug delivery to the brain. His work has been featured in TIME Magazine, CNN, Forbes, Wired, Popular Science, Boston Globe, Boston Magazine, and Harvard Medicine Magazine.